Of these genes, MCM2 and CCNF were significantly (p < 0.05) upregulated in CP CML versus normal progenitor cells suggesting that two key processes that distinguished CP CML from normal progenitors were regulation of DNA replication and repair. This evidence concerns the gene CCNF and chronic myelogenous leukemia, BCR-ABL1 positive.